[1]
Al-Ammiri, H.H. and Al-Derzi, A.R. 2013. Validity of serum Toll-like receptor-2 (TLR-2) in women with breast tumor. Journal of the Faculty of Medicine Baghdad. 55, 2 (Jul. 2013), 152–157. DOI:https://doi.org/10.32007/jfacmedbagdad.552645.